Current Problems in Cardiology
Volume 33, Issue 1 , Pages 7-39 , January 2008

Marfan Syndrome—Diagnosis and Management

References 

  1. Dietz H, Cutting G, Pyeritz RE, et al. Marfan Syndrome caused by a recurrent do novo missense mutation in the fibrillin gene. Lett Nat. 1991;352:337-33
  2. Neptune ER, Frischmeyer PA, Arking DE, et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet. 2003;33(3):407–411
  3. Arbustini E, Marziliano N, Magrassi L. Aneurysm syndromes and TGF-beta receptor mutations. N Engl J Med 2155;355(20):2155.
  4. Boileau C, Jondeau G, Mizuguchi T, et al. Molecular genetics of Marfan syndrome. Curr Opin Cardiol. 2005;20(3):194–200
  5. Ades LC, Sullivan K, Biggin A, et al. FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited. Am J Med Genet Part A. 2006;140(10):1047–1058
  6. Judge DP, Dietz HC. Marfan’s syndrome. Lancet. 2005;366(9501):1965–1976
  7. Baumgartner C, Matyas G, Steinmann B, et al. A bioinformatics framework for genotype-phenotype correlation in humans with Marfan syndrome caused by FBN1 gene mutations. J Biomed Inform. 2006;39(2):171–183
  8. Robinson P, Arteaga-Solis E, Baldock C, et al. The molecular genetics of Marfan syndrome and related disorders. J Med Genet. 2006;43(10):769–787
  9. De Paepe A, Devereux RB, Dietz HC, et al. Revised diagnostic criteria for the Marfan Syndrome. Am J Med Genet. 1996;62:417–426
  10. Judge DP, Biery NJ, Dietz HC. Characterization of microsatellite markers flanking FBN1: utility in the diagnostic evaluation for Marfan syndrome. Am J Med Genet. 2001;99:39–47
  11. McKusick VA. The cardiovascular aspects of Marfan’s Syndrome: a heritable disorder of connective tissue. Circulation. 1955;XI:321–342
  12. Cameron DE, Vricella LA. Valve-sparing aortic root replacement in Marfan syndrome. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005;103–111
  13. Januzzi J, Marayati F, Mehta R, et al. Comparison of aortic dissection in patient with and without Marfan’s syndrome (results from the International Registry of Aortic Dissection). Am J Cardiol. 2004;94:400–402
  14. Januzzi J, Isselbacher E, Fattori R, et al. Characterizing the young patient with aortic dissection: results from the International Registry of Aortic Dissection (IRAD). J Am Coll Cardiol. 2004;43:665–669
  15. Webb GD, David TE. Marfan syndrome: a cardiovascular perspective. In:  Gatzoulis MA,  Webb GD,  Daubeney PEF editor. Diagnosis and management of congenital heart disease. Philadelphia, PA: Churchill Livingstone; 2003;p. 481–486
  16. Roman M, Devereux R, Kramer-Fox R, et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 1989;64:507–512
  17. Engelfriet PM, Boersma E, Tijssen JG, et al. Beyond the root: dilatation of the distal aorta in Marfan’s syndrome. Heart. 2006;92(9):1238–1243
  18. De Backer J, Loeys B, Devos D, et al. A critical analysis of minor cardiovascular criteria in the diagnostic evaluation of patients with Marfan syndrome. Genet Med. 2006;8(7):401–408
  19. Angiolillo DJ, Moreno R, Macaya C. Isolated distal coronary dissection in Marfan syndrome. Ital Heart J. 2004;5(4):305–306
  20. De Backer JF, Devos D, Segers P, et al. Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol. 2007;112(3):353–358
  21. Anton E. Cerebral infarction in a young adult with Marfan syndrome. Int J Cardiol. 2006;112(3):378–379
  22. Harrer JU, Sasse A, Klotzsch C. Intimal flap in a common carotid artery in a patient with Marfan’s syndrome. Ultraschall Med. 2006;27(5):487–488
  23. Espinola-Zavaleta N, Casanova-Garces JM, Munoz Castellanos L, et al. Echocardiometric evaluation of cardiovascular abnormalities in Marfan syndrome. Arch Cardiol Mex. 2005;75(2):133–140
  24. Das BB, Taylor AL, Yetman AT. Left ventricular diastolic dysfunction in children and young adults with Marfan syndrome. Pediatr Cardiol. 2006;27(2):256–258
  25. Chatrath R, Beauchesne LM, Connolly HM, et al. Left ventricular function in the Marfan syndrome without significant valvular regurgitation. Am J Cardiol. 2003;91(7):914–916
  26. Wityk RJ, Zanferrari C, Oppenheimer S. Neurovascular complications of Marfan syndrome: a retrospective, hospital-based study. Stroke. 2002;33(3):680–684
  27. Foran JR, Pyeritz RE, Dietz HC, et al. Characterization of the symptoms associated with dural ectasia in the Marfan patient. Am J Med Genet A. 2005;134(1):58–65
  28. MacKenzie JM, Rankin R. Sudden death due to atlantoaxial subluxation in Marfan syndrome. Am J Forensic Med Pathol. 2003;24(4):369–370
  29. Albornoz G, Coady MA, Roberts M, et al. Familial thoracic aortic aneurysms and dissections—incidence, modes of inheritance, and phenotypic patterns. Ann Thorac Surg. 2006;82(4):1400–1405
  30. Beroukhim RS, Roosevelt G, Yetman AT. Comparison of the pattern of aortic dilation in children with the Marfan’s syndrome versus children with a bicuspid aortic valve. Am J Cardiol. 2006;98(8):1094–1095
  31. Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005;37(3):275–281
  32. Lazarevic AM, Nakatani S, Okita Y, et al. Determinants of rapid progression of aortic root dilatation and complications in Marfan syndrome. Int J Cardiol. 2006;106(2):177–182
  33. Meijboom LJ, Timmermans J, Zwinderman AH, et al. Aortic root growth in men and women with the Marfan’s syndrome. Am J Cardiol. 2005;96(10):1441–1444
  34. Davies RR, Gallo A, Coady MA, et al. Novel measurement of relative aortic size predicts rupture of thoracic aortic aneurysms. Ann Thorac Surg. 2006;81(1):169–177
  35. Nollen GJ, Groenink M, Tijssen JG, et al. Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. Eur Heart J. 2004;25(13):1146–1152
  36. Vitarelli A, Conde Y, Cimino E, et al. Aortic wall mechanics in the Marfan syndrome assessed by transesophageal tissue Doppler echocardiography. Am J Cardiol. 2006;97(4):571–577
  37. Moore AG, Eagle KA, Bruckman D, et al. Choice of computed tomography, transesophageal echocardiography, magnetic resonance imaging, and aortography in acute aortic dissection: International Registry of Acute Aortic Dissection (IRAD). Am J Cardiol. 2002;89(10):1235–123815
  38. Shores J, Berger KR, Murphy EA, et al. Progression of aortic dilatation and the benefit of long-term B-adrenergic blockade in Marfan’s Syndrome. N Engl J Med. 1994;330:1335–1341
  39. Rossi-Foulkes R, Roman MJ, Rosen SE, et al. Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. Am J Cardiol. 1999;83(9):1364–1368
  40. Yetman AT, Bornemeier RA, McCrindle BW. Usefulness of enalapril versus propranolol or atenolol for prevention of aortic dilation in patients with the Marfan syndrome. Am J Cardiol. 2005;95(9):1125–1127
  41. Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science. 2006;312:36–37
  42. Verbraecken J, Declerck A, Van de Heyning P, et al. Evaluation for sleep apnea in patients with Ehlers-Danlos syndrome and Marfan: a questionnaire study. Clin Genet. 2001;60(5):360–365
  43. Verbraecken J, Paelinck BP, Willemen M, et al. Aortic root diameter and nasal intermittent positive airway pressure treatment in Marfan’s syndrome. Clin Genet. 2003;63(2):131–134
  44. Chobanian A, Bakris G, Black H, et al. National Heart (Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The JNC 7 Report). JAMA. 2003;289:2560–2571
  45. Braverman A. Exercise and the Marfan syndrome. Med Sci Sports Exerc. 1998;30:S387–S395
  46. Maron BJ, Chaitman BR, Ackerman MJ, et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109:2807–2816
  47. Wilson W, Taubert KA, Gewitz M, et al. Prevention of Infective Endocarditis (Guidelines from the American Heart Association. A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group). Circulation. 2007;(Apr 19):[Epub ahead of print]
  48. Gott V, Greene P, Alejo D, et al. Replacement of the aortic root in patients with Marfan’s Syndrome. N Eng J Med. 1999;340:1307–1313
  49. Milewicz D, Dietz H, Miller D. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111:e150–e157
  50. Elefteriades JA. Natural history of thoracic aortic aneurysms: indications for surgery and surgical versus nonsurgical risks. Ann Thorac Surg. 2002;74:S1877–S1880
  51. Aomi S, Nakajima M, Nonoyama M, et al. Aortic root replacement using composite valve graft in patients with aortic valve disease and aneurysm of the ascending aorta: twenty years’ experience of late results. Artif Organs. 2002;26(5):467–473
  52. Gott VL, Cameron DE, Alejo DE, et al. Aortic root replacement in 271 Marfan patients: a 24-year experience. Ann Thorac Surg. 2002;73(2):438–443
  53. Zehr KJ, Matloobi A, Connolly HM, et al. Surgical management of the aortic root in patients with Marfan syndrome. J Heart Valve Dis. 2005;14(1):121–128
  54. Birks EJ, Webb C, Child A, et al. Early and long term results of a valve sparing operation for Marfan syndrome. Circulation. 1999;100(suppl 2):29–35
  55. David TE, Feindel CM. An aortic valve-sparing operation for patients with aortic incompetence and aneurysm of ascending aorta. J Thorac Cardiovasc Surg. 1992;103(6):617–621
  56. de Oliveira NC, David TE, Ivanov J, et al. Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J Thorac Cardiovasc Surg. 2003;125(4):789–796
  57. David TE, Feindel CM, Webb GD, et al. Long-term results of aortic valve-sparing operations for aortic root aneurysm. J Thorac Cardiovasc Surg. 2006;132(2):347–354
  58. Kallenbach K, Hagl C, Walles T, et al. Results of valve-sparing aortic root reconstruction in 158 consecutive patients. Ann Thorac Surg. 2002;74(6):2026–2032
  59. Kallenbach K, Karck M, Leyh RG, et al. Valve-sparing aortic root reconstruction in patients with significant aortic insufficiency. Ann Thorac Surg. 2002;74(5):S1765–S1768
  60. Bethea BT, Fitton TP, Alejo DE, et al. Results of aortic valve-sparing operations: experience with remodeling and reimplantation procedures in 65 patients. Ann Thorac Surg. 2004;78:767–772
  61. Pacini D, Settepani F, De Paulis R, et al. Early results of valve-sparing reimplantation procedure using the Valsalva conduit: a multicenter study. Ann Thorac Surg. 2006;82(3):865–871
  62. Hagan P, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897–903
  63. Dake MD, Kato N, Mitchell RS, et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Eng J Med. 1999;340(20):1545–1552
  64. Davies RR, Goldstein LJ, Coady MA, et al. Yearly rupture of dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg. 2002;73(1):17–27
  65. Juvonen T, Ergin MA, Galla JD, et al. Risk factors for rupture of chronic type B dissections. J Thorac Cardiovasc Surg. 1999;117(4):776–786
  66. Trimarchi S, Nienaber CA, Rampoldi V, et al. Role and results of surgery in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2006;114(suppl 1):I357–I364
  67. Bhudia S, Troughton R, Lam B, et al. Mitral valve surgery in the adult Marfan syndrome patient. Ann Thorac Surg. 2006;81:843–848
  68. Tagusari O, Ogino H, Kobayashi J, et al. Should the transverse aortic arch be replaced simultaneously with aortic root replacement for annuloaortic ectasia in Marfan syndrome?. J Thorac Cardiovasc Surg. 2004;127(5):1373–1380
  69. Roux D, Brouchet L, Rousseau H, et al. Treatment of a fistula at the distal anastomosis after Bentall operation with endoluminal covered stent. Ann Thorac Surg. 2002;74(6):2189–2190
  70. Badmanaban B, Mallon P, Campbell N, et al. Repair of left coronary artery aneurysm, recurrent ascending aortic aneurysm, and mitral valve prolapse 19 years after Bentall’s procedure in a patient with Marfan syndrome. J Card Surg. 2004;19(1):59–61
  71. Milano AD, Pratali S, Mecozzi G, et al. Fate of coronary ostial anastomoses after the modified Bentall procedure. Ann of Thorac Surg. 2003;75(6):1797–1801discussion 1802
  72. van Karnebeek CD, Naeff MS, Mulder BJ, et al. Natural history of cardiovascular manifestations in Marfan Syndrome. Arch Dis Child. 2001;84(2):129–137
  73. Ladouceur M, Fermanian C, Lupoglazoff JM, et al. Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. Am J Cardiol. 2007;99:406–409
  74. Cattaneo S, Bethea B, Alejo D, et al. Surgery for aortic root aneurysm in children: a 21-year experience in 50 patients. Ann Thorac Surg. 2004;77:168–176
  75. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2006;48:e1
  76. Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111(11):e150–e157
  77. Morse R, Rockenmaker S, Pyeritz R, et al. Diagnosis and management of infantile Marfan syndrome. Pediatrics. 1990;86:888–895
  78. Geva T, Sanders S, Diogenes M, et al. Two-dimensional and Doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome. Am J Cardiol. 1990;65:1230–1237
  79. Revencu N, Quenum G, Detaille T, et al. Congenital diaphragmatic eventration and bilateral uretero-hydronephrosis in a patient with neonatal Marfan syndrome caused by a mutation in exon 25 of the FBN1 gene and review of the literature. Eur J Pediatr. 2004;163:33–37
  80. Peters K, Apse K, Blackford A, et al. Living with Marfan syndrome: coping with stigma. Clin Genet. 2005;68(1):6–14
  81. Lopes KR, Delezoide AL, Baumann C, et al. Prenatal Marfan syndrome: report of one case and review of the literature. Prenat Diagn. 2006;26(8):696–699
  82. Rossiter J, Repke J, Morales A, et al. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173:1599–1606
  83. Meijboom LJ, Vos FE, Timmermans J, et al. Pregnancy and aortic root growth in the Marfan syndrome: a prospective study. Eur Heart J. 2005;26(9):914–920
  84. Meijboom LJ, Drenthen W, Pieper PG, et al. Obstetric complications in Marfan syndrome. Int J Cardiol. 2006;110(1):53–59
  85. Tilak M, Smith J, Rogers D, et al. Successful near-term pregnancy outcome after repair of a dissecting thoracic aortic aneurysm at 14 weeks gestation. Can J Anaesth. 2005;52(10):1071–1075
  86. Silverman D, Burton K, Gray J, et al. Life Expectancy in the Marfan Syndrome. Am J Cardiol. 1995;75:157–160
  87. Ng CM, Cheng A, Myers LA, et al. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest. 2004;114(11):1586–1592

 The authors have no conflicts of interest to disclose.

PII: S0146-2806(07)00122-3

doi: 10.1016/j.cpcardiol.2007.10.001

Current Problems in Cardiology
Volume 33, Issue 1 , Pages 7-39 , January 2008